Logo
Neuren Pharmaceuticals

Refining Clinician- and Caregiver-Reported Outcome Measures for Evaluating Phelan-McDermid Syndrome


0

likes

0

questions

0

company answers

Ask a question


Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Neuren Pharmaceuticals Limited a question about this update.